Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	TOX PTF1A NOC2L PARG CALCOCO1 CHD1 CHD7 SSRP1 MEIS1 SBNO2 KAT7 JARID2 SAMD11 MLLT1 PAX3	6.60e-05	739	126	15	GO:0003682
GeneOntologyMolecularFunction	SAM domain binding	DGKH SAMD11	1.18e-04	3	126	2	GO:0032093
GeneOntologyCellularComponent	chromatin	PTF1A NOC2L BACH2 PARG CALCOCO1 NPAS3 NKX3-2 HLX CHD1 CHD7 XPC FOXN3 SSRP1 WDR76 FAAP100 SCX MEIS1 KAT7 JARID2 CTR9 BRPF1 NFKB2 ANKRD11 PAX3 KDM4B INO80E	5.46e-07	1480	125	26	GO:0000785
GeneOntologyCellularComponent	costamere	ANK2 SYNM CMYA5	2.96e-04	22	125	3	GO:0043034
GeneOntologyCellularComponent	cortical microtubule cytoskeleton	CLASP1 CLASP2	3.51e-04	5	125	2	GO:0030981
GeneOntologyCellularComponent	TORC1 complex	AKT1S1 MTOR	5.24e-04	6	125	2	GO:0031931
GeneOntologyCellularComponent	basal cortex	CLASP1 CLASP2	7.30e-04	7	125	2	GO:0045180
GeneOntologyCellularComponent	H3 histone acetyltransferase complex	KAT7 BRPF1	9.70e-04	8	125	2	GO:0070775
MousePheno	decreased transitional stage B cell number	BACH2 MTOR NFKB2 AKAP13 CARD11	2.33e-05	46	105	5	MP:0008190
MousePheno	abnormal pharyngeal arch artery morphology	CHD7 KAT7 CCM2 PAX3 PRRC2B	2.59e-05	47	105	5	MP:0002672
MousePheno	hydrometra	CLASP1 SYBU NAA38 LPIN2 CARD11 KIF13A	7.42e-05	94	105	6	MP:0009709
MousePheno	abnormal transitional stage B cell morphology	BACH2 MTOR NFKB2 AKAP13 CARD11	1.25e-04	65	105	5	MP:0008188
MousePheno	decreased effector memory CD8-positive, alpha-beta T cell number	BACH2 NFKB2 CARD11	1.41e-04	14	105	3	MP:0010851
MousePheno	tympanic ring hypoplasia	TCOF1 NKX3-2	1.67e-04	3	105	2	MP:0030084
MousePheno	absent nasal pit	TCOF1 CHD7	1.67e-04	3	105	2	MP:0030060
MousePheno	enlarged brain ventricles	ANK2 NRDC NPAS3 CHD7 KIDINS220 KDM4B CDON	1.72e-04	156	105	7	MP:0011380
MousePheno	decreased circulating total protein level	KIF21B AMFR CALCOCO1 CHD7 AKAP9 USP54 KDM4B	2.17e-04	162	105	7	MP:0005567
MousePheno	abnormal brain ventricle size	ANK2 NRDC NPAS3 CHD7 KIDINS220 KDM4B CDON	2.34e-04	164	105	7	MP:0013229
MousePheno	abnormal lateral ventricle morphology	ANK2 NRDC NPAS3 CHD7 PAX3 KDM4B CDON	2.34e-04	164	105	7	MP:0000823
MousePheno	small middle ear ossicles	TCOF1 NKX3-2 CHD7	2.59e-04	17	105	3	MP:0030123
MousePheno	abnormal pharyngeal arch morphology	TCOF1 CHD7 KAT7 CCM2 AKAP13 PAX3 PRRC2B	3.02e-04	171	105	7	MP:0002884
MousePheno	dilated dorsal aorta	SCX KAT7 CCM2	3.10e-04	18	105	3	MP:0004068
MousePheno	abnormal sixth pharyngeal arch artery morphology	CHD7 PAX3 PRRC2B	3.10e-04	18	105	3	MP:0006355
MousePheno	abnormal sixth pharyngeal arch morphology	CHD7 PAX3 PRRC2B	3.10e-04	18	105	3	MP:0006347
MousePheno	increased immature B cell number	BACH2 NFKB2 AKAP13 CARD11	3.24e-04	44	105	4	MP:0008214
MousePheno	abnormal basicranium morphology	NKX3-2 CHD7 FOXN3 PAX3 PRRC2B CDON	3.25e-04	123	105	6	MP:0010029
MousePheno	decreased brain internal capsule size	ANK2 CHD7	3.32e-04	4	105	2	MP:0012462
MousePheno	abnormal dorsal aorta morphology	SCX KAT7 CCM2 PAX3 PRRC2B	3.54e-04	81	105	5	MP:0004787
Domain	BAT2_N	PRRC2A PRRC2B	1.37e-04	3	127	2	PF07001
Domain	BAT2_N	PRRC2A PRRC2B	1.37e-04	3	127	2	IPR009738
Domain	PRRC2	PRRC2A PRRC2B	1.37e-04	3	127	2	IPR033184
Domain	CLASP_N	CLASP1 CLASP2	2.73e-04	4	127	2	PF12348
Domain	CLASP_N_dom	CLASP1 CLASP2	2.73e-04	4	127	2	IPR024395
Domain	FCH	FCHO1 ARHGAP4 PACSIN2	4.30e-04	22	127	3	PF00611
Domain	FCH	FCHO1 ARHGAP4 PACSIN2	4.30e-04	22	127	3	SM00055
Domain	FCH_dom	FCHO1 ARHGAP4 PACSIN2	4.92e-04	23	127	3	IPR001060
Domain	DEATH-like_dom	ANK2 MADD NFKB2 CARD6 CARD11	5.77e-04	99	127	5	IPR011029
Domain	F_BAR	FCHO1 ARHGAP4 PACSIN2	6.33e-04	25	127	3	IPR031160
Domain	F_BAR	FCHO1 ARHGAP4 PACSIN2	6.33e-04	25	127	3	PS51741
Domain	HEAT	CEP104 CLASP1 CLASP2 MTOR	6.51e-04	58	127	4	IPR000357
Domain	HEAT_REPEAT	CEP104 CLASP1 CLASP2 MTOR	1.32e-03	70	127	4	PS50077
Domain	JmjN	JARID2 KDM4B	1.99e-03	10	127	2	SM00545
Domain	JmjN	JARID2 KDM4B	1.99e-03	10	127	2	PF02375
Domain	JMJN	JARID2 KDM4B	1.99e-03	10	127	2	PS51183
Domain	JmjN	JARID2 KDM4B	1.99e-03	10	127	2	IPR003349
Domain	Death_domain	ANK2 MADD NFKB2	2.18e-03	38	127	3	IPR000488
Domain	DEATH_DOMAIN	ANK2 MADD NFKB2	2.18e-03	38	127	3	PS50017
Domain	-	ANK2 NFKB2 CARD6 CARD11	3.73e-03	93	127	4	1.10.533.10
Domain	CNH	CDC42BPB MAP4K4	3.96e-03	14	127	2	SM00036
Domain	HEAT	CEP104 CLASP1 CLASP2	4.25e-03	48	127	3	PF02985
Domain	CNH	CDC42BPB MAP4K4	4.55e-03	15	127	2	PF00780
Domain	CNH	CDC42BPB MAP4K4	4.55e-03	15	127	2	PS50219
Domain	CNH_dom	CDC42BPB MAP4K4	4.55e-03	15	127	2	IPR001180
Domain	HMG_box	SP100 TOX SSRP1	5.61e-03	53	127	3	PF00505
Domain	HMG_BOX_2	SP100 TOX SSRP1	5.92e-03	54	127	3	PS50118
Domain	HMG	SP100 TOX SSRP1	5.92e-03	54	127	3	SM00398
Domain	-	SP100 TOX SSRP1	6.23e-03	55	127	3	1.10.30.10
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CLASP1 DTL CLASP2 SSRP1 PRAG1 AKT1S1 MADD CCDC88A AKAP9 SYNJ2 MTOR SAMD11 ANKRD11 RAB11FIP5 AKAP13 NUP93 USP54 SSH2 KIF13A MAP4K4 BICC1	6.33e-12	861	127	21	36931259
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	HIRIP3 CLASP1 TCOF1 PARG ZNF507 FNBP4 RRP15 CHD7 XPC GPATCH8 SSRP1 INTS3 AKT1S1 CTR9 BRPF1 MAP4K4 PRRC2A KDM4B	4.99e-10	774	127	18	15302935
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DCAF8 ANK2 TCOF1 SYNM NOC2L FNBP4 RRP15 CHD1 CLASP2 SSRP1 CDC42BPB NSRP1 SNX29 CCDC88A KIDINS220 AKAP9 CTR9 ANKRD11 RAB11FIP5 AKAP13 TACC1 MAP4K4 PACSIN2	4.36e-09	1487	127	23	33957083
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	DCAF8 HIRIP3 CLASP1 TCOF1 NOC2L WDR70 CLASP2 SSRP1 AKT1S1 MADD KAT7 CCDC88A MTOR CTR9 NFKB2 RAB11FIP5 SSH2 SNAPC2 MAP4K4	8.01e-09	1038	127	19	26673895
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	CLASP1 DTL WDR70 CHD1 CLASP2 CHD7 GPATCH8 MADD CCDC88A SYNJ2 SECISBP2 AKAP13 TACC1 USP54 MAP4K4 PACSIN2	1.20e-08	733	127	16	34672954
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MIER2 CENPT HIRIP3 WDR70 RRP15 CHD1 CHD7 XPC GPATCH8 SSRP1 WDR76 KAT7 BRPF1 KDM4B	5.44e-08	608	127	14	36089195
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	NRDC TAGAP WWP1 DZIP1L DTL ZNF507 CLASP2 CHD7 GPATCH8 ZCCHC2 MADD SBNO2 KAT7 TCP11L2 CTR9 KIF13A BICC1 PACSIN2	8.90e-08	1084	127	18	11544199
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	CHD7 SSRP1 KAT7 JARID2 BRPF1 ANKRD11 KDM4B INO80E	1.23e-07	157	127	8	30186101
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CLASP1 TCOF1 BACH2 DTL ZNF507 CHD7 ZCCHC2 CCDC88A CTR9 NFKB2 RAB11FIP5 SECISBP2 PRRC2B	2.65e-07	588	127	13	38580884
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CACNB3 DCAF8 WWP1 CALCOCO1 WDR70 FNBP4 DGKH CLASP2 FOXN3 INTS3 CDC42BPB NSRP1 SNX29 SBNO2 PPARGC1B KIDINS220 SYNJ2 ANKRD11 AKAP13 KDM4B	4.81e-07	1489	127	20	28611215
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF21B ANK2 CLASP1 TCOF1 CALCOCO1 CLASP2 CHD7 CDC42BPB CCDC88A AKAP9 MTOR SSH2 MAP4K4 PRRC2A GOLGA1 PRRC2B	4.89e-07	963	127	16	28671696
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	AMFR DCAF8 NRDC CLASP1 TCOF1 DTL WDR70 CHD1 FAAP100 KIDINS220 PTPRO MTOR CTR9 NUP93 PRRC2A PRRC2B	5.68e-07	974	127	16	28675297
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SYNM CCDC88A KIDINS220 RAB11FIP5 SECISBP2 TACC1 USP54 MAP4K4 PRRC2B	5.75e-07	263	127	9	34702444
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	NRDC PARG LMBRD2 INTS3 MADD SBNO2 PHKA2 CCDC88A CTR9 CARD6 AKAP13 MAP4K4 PRRC2B	8.17e-07	650	127	13	38777146
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	CLASP1 CALCOCO1 WDR70 CLASP2 FCHO1 PNMA8B AKAP13 CARD11 PRRC2A PRRC2B	9.15e-07	361	127	10	26167880
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	ANK2 PCNX3 TMEM121B BACH2 CYBC1 FNBP4 CHD1 GPATCH8 WDR76 FAAP100 ZNF785 TCAIM SAMD11 KANK4 USP54 PACSIN2 PRRC2B	2.20e-06	1215	127	17	15146197
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	DCAF8 SYBU NFKB2 LPIN2 AKAP13 TACC1 USP54 PRRC2A	2.36e-06	232	127	8	25515538
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PCNX3 WWP1 WDR70 CLASP2 PRAG1 FAAP100 CDC42BPB MADD SBNO2 AATK MTOR NFKB2 ANKRD11 MLLT1 AKAP13 PRRC2B	2.91e-06	1105	127	16	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SP100 DCAF8 TCOF1 WWP1 BACH2 XPC SSRP1 NSRP1 KAT7 ARHGAP4 BRPF1 RAB11FIP5 MLLT1 USP54 PRRC2B INO80E	3.30e-06	1116	127	16	31753913
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	KIF21B TCOF1 CLASP2 SYBU RTN2 AKT1S1 SSH2 MAP4K4	3.63e-06	246	127	8	15345747
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CEP104 KIF21B ZNF507 FNBP4 ARHGAP4 CCDC88A SYNJ2 RAB11FIP5 NUP93 MAP4K4 KDM4B	4.13e-06	529	127	11	14621295
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	MIER2 CLASP1 FNBP4 CHD7 NSRP1 JARID2 ANKRD11 TACC1 MAP4K4 PRRC2A PACSIN2	4.68e-06	536	127	11	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	MIER2 CLASP1 FNBP4 CHD7 NSRP1 JARID2 ANKRD11 TACC1 MAP4K4 PRRC2A PACSIN2	4.85e-06	538	127	11	10512203
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	HIRIP3 TCOF1 NOC2L FNBP4 RRP15 CHD7 XPC GPATCH8 SSRP1 WDR76 INTS3 KAT7 CTR9 ANKRD11 MLLT1 NUP93 INO80E	5.08e-06	1294	127	17	30804502
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	HIRIP3 CLASP1 CHD1 GPATCH8 PRAG1 KAT7 PHKA2 AKAP9 RTL1 CTR9 MLLT1 CCDC106 FGFR4 MAP4K4	6.42e-06	910	127	14	36736316
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	NRDC CHD1 NFKB2 LPIN2 TACC1 USP54	7.93e-06	128	127	6	25332235
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PCNX3 CLASP1 NOC2L RRP15 CHD1 CLASP2 CHD7 XPC GPATCH8 SSRP1 CDC42BPB JARID2 KIDINS220 CTR9 ANKRD11 MLLT1 PRRC2A INO80E	8.80e-06	1497	127	18	31527615
Pubmed	Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.	ANK2 CLASP1 CLASP2 AKAP9	1.02e-05	37	127	4	27565344
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	AMFR DCAF8 TMEM121B WDR70 CLASP2 MADD CCM2 KANK4 PRRC2A PRRC2B	1.03e-05	475	127	10	31040226
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ANK2 CLASP1 TCOF1 FNBP4 RRP15 CLASP2 CHD7 XPC SSRP1 WDR76 CDC42BPB AKAP9 CCDC106 NUP93 PRRC2A PRRC2B INO80E	1.08e-05	1371	127	17	36244648
Pubmed	Mammalian CLASP1 and CLASP2 cooperate to ensure mitotic fidelity by regulating spindle and kinetochore function.	CLASP1 CLASP2	1.32e-05	2	127	2	16914514
Pubmed	Mammalian CLASPs are required for mitotic spindle organization and kinetochore alignment.	CLASP1 CLASP2	1.32e-05	2	127	2	16866869
Pubmed	Golgi-derived CLASP-dependent microtubules control Golgi organization and polarized trafficking in motile cells.	CLASP1 CLASP2	1.32e-05	2	127	2	19701196
Pubmed	CHD1 interacts with SSRP1 and depends on both its chromodomain and its ATPase/helicase-like domain for proper association with chromatin.	CHD1 SSRP1	1.32e-05	2	127	2	10199952
Pubmed	Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics.	CLASP1 CLASP2	1.32e-05	2	127	2	12837247
Pubmed	Gene Body Methylation of the Lymphocyte-Specific Gene CARD11 Results in Its Overexpression and Regulates Cancer mTOR Signaling.	MTOR CARD11	1.32e-05	2	127	2	34348992
Pubmed	Proteomic analysis of Girdin-interacting proteins in migrating new neurons in the postnatal mouse brain.	CLASP2 CCDC88A	1.32e-05	2	127	2	24211587
Pubmed	Mast, a conserved microtubule-associated protein required for bipolar mitotic spindle organization.	CLASP1 CLASP2	1.32e-05	2	127	2	10899121
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	NRDC GPATCH8 TCP11L2 NFKB2 USP54 PLEKHH2 PRRC2A	2.06e-05	226	127	7	25900982
Pubmed	A TGFβ-Smad4-Fgf6 signaling cascade controls myogenic differentiation and myoblast fusion during tongue development.	SCX PAX3 FGFR4	2.57e-05	16	127	3	22438570
Pubmed	Transcription factors Mesp2 and Paraxis have critical roles in axial musculoskeletal formation.	NKX3-2 SCX PAX3	2.57e-05	16	127	3	17477400
Pubmed	Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryo.	SCX PAX3 FGFR4	3.11e-05	17	127	3	15788460
Pubmed	Tagging genes with cassette-exchange sites.	CLASP2 FOXN3 GPATCH8 CHM KAT7 PPP1R37 SECISBP2 AKAP13	3.38e-05	335	127	8	15741177
Pubmed	Role of PRAS40 in Akt and mTOR signaling in health and disease.	AKT1S1 MTOR	3.96e-05	3	127	2	22354785
Pubmed	The CENP-T/-W complex is a binding partner of the histone chaperone FACT.	CENPT SSRP1	3.96e-05	3	127	2	27284163
Pubmed	CLASP2 Links Reelin to the Cytoskeleton during Neocortical Development.	CLASP1 CLASP2	3.96e-05	3	127	2	28285824
Pubmed	Chromatin remodeler CHD1 promotes XPC-to-TFIIH handover of nucleosomal UV lesions in nucleotide excision repair.	CHD1 XPC	3.96e-05	3	127	2	29018037
Pubmed	JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.	JARID2 PAX3	3.96e-05	3	127	2	23435416
Pubmed	The miR-378/PGC1β/mTOR axis as an alternative mechanism to promote autophagy during adipogenesis.	PPARGC1B MTOR	3.96e-05	3	127	2	33716136
Pubmed	F-actin rearrangement is regulated by mTORC2/Akt/Girdin in mouse fertilized eggs.	CCDC88A MTOR	3.96e-05	3	127	2	27666957
Pubmed	Regulation of retinal amacrine cell generation by miR-216b and Foxn3.	PTF1A FOXN3	3.96e-05	3	127	2	34919141
Pubmed	Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments.	SCX PAX3	3.96e-05	3	127	2	11585810
Pubmed	PPAR Gamma Coactivator 1 Beta (PGC-1β) Reduces Mammalian Target of Rapamycin (mTOR) Expression via a SIRT1-Dependent Mechanism in Neurons.	PPARGC1B MTOR	3.96e-05	3	127	2	27631411
Pubmed	Asymmetric CLASP-dependent nucleation of noncentrosomal microtubules at the trans-Golgi network.	CLASP1 CLASP2	3.96e-05	3	127	2	17543864
Pubmed	CLASPs attach microtubule plus ends to the cell cortex through a complex with LL5beta.	CLASP1 CLASP2	3.96e-05	3	127	2	16824950
Pubmed	The binding of PRAS40 to 14-3-3 proteins is not required for activation of mTORC1 signalling by phorbol esters/ERK.	AKT1S1 MTOR	3.96e-05	3	127	2	18215133
Pubmed	Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation.	AKT1S1 MTOR	3.96e-05	3	127	2	18372248
Pubmed	CLIPs and CLASPs and cellular dynamics.	CLASP1 CLASP2	3.96e-05	3	127	2	15928712
Pubmed	Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40.	AKT1S1 MTOR	3.96e-05	3	127	2	21886838
Pubmed	Gene Expression and Missplicing in the Corneal Endothelium of Patients With a TCF4 Trinucleotide Repeat Expansion Without Fuchs' Endothelial Corneal Dystrophy.	AKAP13 KIF13A	3.96e-05	3	127	2	31469403
Pubmed	Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104.	MTOR FGFR4	3.96e-05	3	127	2	32111983
Pubmed	CLASPs prevent irreversible multipolarity by ensuring spindle-pole resistance to traction forces during chromosome alignment.	CLASP1 CLASP2	3.96e-05	3	127	2	22307330
Pubmed	PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma.	PAX3 FGFR4	3.96e-05	3	127	2	21882254
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	TCOF1 NOC2L FNBP4 RRP15 CHD1 XPC SYBU SSRP1 KAT7 BRPF1 NUP93 PRRC2A	6.71e-05	847	127	12	35850772
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	WWP1 LMBRD2 CDC42BPB MADD CCDC88A SYNJ2 NFKB2 RAB11FIP5 KIF13A MAP4K4 PACSIN2	6.94e-05	719	127	11	35337019
Pubmed	Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.	KIF21B TAGAP BACH2 MUC19 SBNO2	6.96e-05	116	127	5	21102463
Pubmed	Experimental and computational approaches yield a high-resolution, 1-Mb physical map of the region harboring the mouse t haplotype sterility factor, tcs1.	TAGAP SYNJ2	7.90e-05	4	127	2	11471064
Pubmed	T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.	MTOR CARD11	7.90e-05	4	127	2	24917592
Pubmed	Inappropriate p53 activation during development induces features of CHARGE syndrome.	CHD7 PAX3	7.90e-05	4	127	2	25119037
Pubmed	Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway.	AKT1S1 MTOR	7.90e-05	4	127	2	25531317
Pubmed	The mechanism of insulin-stimulated 4E-BP protein binding to mammalian target of rapamycin (mTOR) complex 1 and its contribution to mTOR complex 1 signaling.	AKT1S1 MTOR	7.90e-05	4	127	2	21914810
Pubmed	S9, a 19 S proteasome subunit interacting with ubiquitinated NF-kappaB2/p100.	NFKB2 MAP4K4	7.90e-05	4	127	2	12185077
Pubmed	The Chromatin Regulator BRPF3 Preferentially Activates the HBO1 Acetyltransferase but Is Dispensable for Mouse Development and Survival.	KAT7 BRPF1	7.90e-05	4	127	2	26677226
Pubmed	Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity.	KAT7 BRPF1	7.90e-05	4	127	2	24065767
Pubmed	Map4k4 negatively regulates peroxisome proliferator-activated receptor (PPAR) gamma protein translation by suppressing the mammalian target of rapamycin (mTOR) signaling pathway in cultured adipocytes.	MTOR MAP4K4	7.90e-05	4	127	2	20038583
Pubmed	SOGA1 and SOGA2/MTCL1 are CLASP-interacting proteins required for faithful chromosome segregation in human cells.	CLASP1 CLASP2	7.90e-05	4	127	2	33587225
Pubmed	Transcription factor TEAD2 is involved in neural tube closure.	PAX3 FGFR4	7.90e-05	4	127	2	17868131
Pubmed	CENP-H-containing complex facilitates centromere deposition of CENP-A in cooperation with FACT and CHD1.	CHD1 SSRP1	7.90e-05	4	127	2	19625449
Pubmed	Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism.	AKT1S1 MTOR	7.90e-05	4	127	2	21266573
Pubmed	Interplay of Nkx3.2, Sox9 and Pax3 regulates chondrogenic differentiation of muscle progenitor cells.	NKX3-2 PAX3	7.90e-05	4	127	2	22768305
Pubmed	PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex.	AKT1S1 MTOR	7.90e-05	4	127	2	17604271
Pubmed	BOC, an Ig superfamily member, associates with CDO to positively regulate myogenic differentiation.	PAX3 CDON	7.90e-05	4	127	2	11782431
Pubmed	Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma.	PTF1A MTOR	7.90e-05	4	127	2	26683340
Pubmed	MTOR inhibitor-based combination therapies for pancreatic cancer.	PTF1A MTOR	7.90e-05	4	127	2	29384525
Pubmed	Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.	AKT1S1 MTOR	7.90e-05	4	127	2	19114562
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	HIRIP3 TCOF1 DTL NSRP1 KAT7 CTR9 AKAP13 KIF13A PRRC2A	1.01e-04	503	127	9	16964243
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	TCOF1 FNBP4 CDC42BPB KIDINS220 USP54 PRRC2A	1.03e-04	202	127	6	24639526
Pubmed	Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV.	NRDC TCOF1 SSRP1	1.03e-04	25	127	3	15385968
Pubmed	Meis homeobox genes control progenitor competence in the retina.	PTF1A MEIS1 CDON	1.03e-04	25	127	3	33723039
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	HIRIP3 NOC2L CHD7 XPC SSRP1 WDR76 KAT7 PRRC2A	1.05e-04	394	127	8	27248496
Pubmed	Protein phosphatase 1α interacting proteins in the human brain.	AATK PHACTR3 LPIN2 MAP4K4	1.09e-04	67	127	4	22321011
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	CLASP1 CLASP2 SNX29 CCDC88A KIDINS220 NFKB2	1.24e-04	209	127	6	36779422
Pubmed	A census of human transcription factors: function, expression and evolution.	SP100 CENPT PTF1A BACH2 NPAS3 NKX3-2 HLX FOXN3 MEIS1 NFKB2 MLLT1 PAX3	1.29e-04	908	127	12	19274049
Pubmed	Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage.	AKT1S1 MTOR	1.31e-04	5	127	2	20068142
Pubmed	Six1 is not involved in limb tendon development, but is expressed in limb connective tissue under Shh regulation.	SCX PAX3	1.31e-04	5	127	2	15804569
Pubmed	Role of CLASP2 in microtubule stabilization and the regulation of persistent motility.	CLASP1 CLASP2	1.31e-04	5	127	2	17113391
Pubmed	A Chromatin Accessibility Atlas of the Developing Human Telencephalon.	CHD7 KCNQ3	1.31e-04	5	127	2	32610082
Pubmed	Epiblast integrity requires CLASP and Dystroglycan-mediated microtubule anchoring to the basal cortex.	CLASP1 CLASP2	1.31e-04	5	127	2	23940118
Pubmed	CLASP1 and CLASP2 bind to EB1 and regulate microtubule plus-end dynamics at the cell cortex.	CLASP1 CLASP2	1.31e-04	5	127	2	15631994
Pubmed	Prickle1 promotes focal adhesion disassembly in cooperation with the CLASP-LL5β complex in migrating cells.	CLASP1 CLASP2	1.31e-04	5	127	2	27378169
Interaction	MAPRE3 interactions	CEP104 CLASP1 CLASP2 SYBU FCHO1 CCDC88A AKAP9 SYNJ2 SECISBP2 TACC1 MAP4K4 PRRC2A	2.48e-08	230	127	12	int:MAPRE3
Interaction	MAPRE1 interactions	CEP104 CLASP1 CYBC1 RRP15 CLASP2 SYBU FCHO1 JARID2 CCDC88A AKAP9 SYNJ2 TACC1 NUP93 FGFR4 PRRC2A GOLGA1 PRRC2B	2.52e-08	514	127	17	int:MAPRE1
Interaction	POLR1G interactions	TCOF1 NOC2L WDR70 FAXC RRP15 CHD1 CHD7 XPC SSRP1 KAT7 CTR9 BRPF1 NFKB2 ANKRD11 MLLT1 NUP93	7.78e-08	489	127	16	int:POLR1G
Interaction	SRPK2 interactions	HIRIP3 CLASP1 TCOF1 NOC2L CALCOCO1 WDR70 RRP15 CLASP2 FOXN3 GPATCH8 FCHO1 NSRP1 PNMA8B CCM2 AKAP13 CARD11 PRRC2A PRRC2B	5.84e-07	717	127	18	int:SRPK2
Interaction	CSNK2B interactions	DCAF8 HIRIP3 TCOF1 RRP15 XPC SSRP1 WDR76 CDC42BPB MADD KAT7 CTR9 BRPF1 ANKRD11 CCDC106 MAP4K4 INO80E	2.03e-06	625	127	16	int:CSNK2B
Interaction	POLR1E interactions	TCOF1 NOC2L FAXC RRP15 CHD1 CHD7 XPC SSRP1 KAT7 CTR9 NFKB2 MLLT1	2.24e-06	350	127	12	int:POLR1E
Interaction	H2BC8 interactions	CENPT HIRIP3 PARG WDR70 RRP15 CHD1 CHD7 XPC SSRP1 WDR76 INTS3 NSRP1 KAT7 BRPF1 KDM4B	3.54e-06	576	127	15	int:H2BC8
Interaction	SYT2 interactions	CYBC1 WDR70 GPATCH8 MADD CTR9 BRPF1 MLLT1 MAP4K4	4.96e-06	150	127	8	int:SYT2
Interaction	FBXW11 interactions	DCAF8 NRDC CHD1 SYBU FOXN3 AATK NFKB2 LPIN2 AKAP13 TACC1 USP54 PLEKHH2 PRRC2A	9.31e-06	473	127	13	int:FBXW11
Interaction	DDX23 interactions	TCOF1 NOC2L WDR70 RRP15 CHD1 XPC GPATCH8 SSRP1 NSRP1 CTR9 BRPF1 ANKRD11 MLLT1	1.09e-05	480	127	13	int:DDX23
Interaction	YWHAH interactions	KIF21B CLASP1 DTL CLASP2 SSRP1 PRAG1 AKT1S1 MADD CCDC88A AKAP9 SYNJ2 MTOR SAMD11 ANKRD11 RAB11FIP5 AKAP13 USP54 SSH2 MAP4K4 BICC1	1.83e-05	1102	127	20	int:YWHAH
Interaction	PLCD4 interactions	TCOF1 WDR70 BRPF1 MLLT1	4.72e-05	32	127	4	int:PLCD4
Interaction	S100A2 interactions	DGKH WDR76 FAAP100 KAT7 CCDC88A PPP1R37 MLLT1 CCDC106 PAX3 USP54 INO80E	6.07e-05	412	127	11	int:S100A2
Interaction	CCDC71 interactions	XPC SSRP1 WDR76 AKAP9 PACSIN2	9.16e-05	72	127	5	int:CCDC71
Interaction	YWHAG interactions	KIF21B CLASP1 DZIP1L DTL CLASP2 PRAG1 AKT1S1 CCDC88A AKAP9 SYNJ2 MTOR SAMD11 ANKRD11 RAB11FIP5 AKAP13 USP54 SSH2 KIF13A MAP4K4 BICC1	1.04e-04	1248	127	20	int:YWHAG
Interaction	BTRC interactions	NRDC TCOF1 NKX3-2 CHD1 FOXN3 GPATCH8 FCHO1 AATK TCP11L2 NFKB2 LPIN2 TACC1 USP54 PRRC2A PRRC2B	1.11e-04	775	127	15	int:BTRC
Interaction	SFN interactions	CLASP1 DTL CLASP2 KAT7 CCDC88A AKAP9 SYNJ2 MTOR AKAP13 NUP93 USP54 SSH2 KIF13A MAP4K4	1.20e-04	692	127	14	int:SFN
Interaction	H2BC21 interactions	HIRIP3 NOC2L FNBP4 CHD7 XPC SSRP1 WDR76 INTS3 KAT7 CTR9 BRPF1 MLLT1 MAP4K4 PRRC2A	1.27e-04	696	127	14	int:H2BC21
Interaction	WDR48 interactions	TCOF1 WDR70 DACT2 FAXC CLASP2 CMYA5 MGARP	1.32e-04	177	127	7	int:WDR48
Interaction	CENPA interactions	CENPT HIRIP3 CHD1 CHD7 XPC SSRP1 KAT7 BRPF1 ANKRD11 MLLT1	1.40e-04	377	127	10	int:CENPA
Interaction	CLIP1 interactions	CLASP1 CLASP2 CCDC88A AKAP9 MTOR NUP93 PACSIN2	1.62e-04	183	127	7	int:CLIP1
Interaction	R3HDM2 interactions	ZCCHC2 SECISBP2 USP54 PRRC2A BICC1 PRRC2B	1.68e-04	129	127	6	int:R3HDM2
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	SYNM CMYA5 AKAP9 AKAP13	8.98e-06	29	83	4	396
GeneFamily	MTOR complex 1\|MTOR complex 2	AKT1S1 MTOR	1.24e-04	4	83	2	1332
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	FCHO1 ARHGAP4 PACSIN2	1.55e-04	23	83	3	1288
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	NOC2L AATK AKAP9 PHACTR3 PPP1R37	1.47e-03	181	83	5	694
GeneFamily	WD repeat domain containing\|DDB1 and CUL4 associated factors	DCAF8 DTL	3.04e-03	18	83	2	498
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	KIF21B CACNB3 ANK2 TMEM121B BACH2 MUC19 NPAS3 FAXC SYBU FOXN3 PNMA8B PPARGC1B CCDC88A AATK AKAP9 PTPRO SAMD11 PHACTR3 KCNQ3 SSH2 KIF13A PRRC2B CDON	3.29e-09	1106	127	23	M39071
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	KIF21B TOX NRDC TAGAP CYBC1 FNBP4 CHD1 GPATCH8 NAA38 SBNO2 JARID2 ARHGAP4 CCDC88A KIDINS220 AKAP9 LPIN2 ANKRD11 SECISBP2 AKAP13 CARD11 TACC1 SSH2 PRRC2B	7.42e-07	1492	127	23	M40023
Coexpression	GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN	DZIP1L FNBP4 SNX29 SCARF1 BRPF1 ANKRD11 SECISBP2 GOLGA1	8.78e-07	154	127	8	M6824
Coexpression	GSE11386_NAIVE_VS_MEMORY_BCELL_DN	TOX BACH2 SIDT1 FNBP4 CMYA5 AKAP9 AKAP13 KIF13A	1.07e-06	158	127	8	M372
Coexpression	GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP	DCAF8 BACH2 XPC CCM2 TCP11L2 CTR9 CARD6 SSH2	5.94e-06	199	127	8	M3071
Coexpression	GSE14350_IL2RB_KO_VS_WT_TEFF_UP	BACH2 FOXN3 PHKA2 NFKB2 RAB11FIP5 TACC1 SSH2 KIF13A	6.16e-06	200	127	8	M3423
Coexpression	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	TCOF1 FNBP4 HLX MADD SBNO2 AKAP13 PRRC2A	3.30e-05	184	127	7	M19988
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	KIF21B ANK2 TMEM121B BACH2 MUC19 NPAS3 SYBU PNMA8B PPARGC1B CCDC88A AATK AKAP9 PHACTR3	3.84e-05	703	127	13	M39070
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRN	KIF21B CACNB3 ANK2 TMEM121B FAXC SYBU PTPRO PHACTR3 KCNQ3	3.86e-05	335	127	9	M39065
Coexpression	GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP	NRDC WWP1 FOXN3 SBNO2 NFKB2 LPIN2 PRRC2B	5.42e-05	199	127	7	M8767
Coexpression	GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN	KIF21B FOXN3 CDC42BPB SBNO2 ARHGAP4 AKAP13 SSH2	5.59e-05	200	127	7	M9472
Coexpression	GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN	CACNB3 WWP1 NPAS3 HLX CHD1 SCARF1 RAB11FIP5	5.59e-05	200	127	7	M9411
Coexpression	GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN	KIF21B TAGAP MADD TCP11L2 PTPRO CARD6 SSH2	5.59e-05	200	127	7	M5980
Coexpression	GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN	AMFR CHD1 GPATCH8 SSRP1 TCAIM AKAP13 USP54	5.59e-05	200	127	7	M7372
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SP100 CLASP1 WWP1 PARG RNF13 CHD1 CLASP2 FOXN3 GPATCH8 JARID2 KIDINS220 AKAP9 SYNJ2 AKAP13	7.19e-05	856	127	14	M4500
Coexpression	FAN_EMBRYONIC_CTX_OLIG	ANO4 CEP104 LARP6 RNF13 CLASP2 SNX29 AATK TCP11L2 SYNJ2 KANK4 SSH2 KIF13A MAP4K4	7.80e-05	754	127	13	M39037
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	KIF21B CACNB3 ANK2 TMEM121B MUC19 SYBU AATK PTPRO SAMD11 PHACTR3	9.23e-05	465	127	10	M39066
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	ANK2 CLASP1 RRP15 CHD7 SNX29 MEIS1 JARID2 CTR9 KANK4 PAX3 FGFR4 SSH2 MAP4K4 PRRC2B CDON	1.14e-04	1009	127	15	M157
Coexpression	ZHONG_PFC_C3_MICROGLIA	KIF21B CACNB3 ANK2 TMEM121B SYBU FCHO1 PTPRO PHACTR3 NUP93 KDM4B	1.37e-04	488	127	10	M39104
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL	MIER2 KIF21B TOX SYNM TAGAP FAXC DGKH SYNJ2 MLLT1 PACSIN2 CDON	1.42e-04	589	127	11	M45662
CoexpressionAtlas	alpha beta T cells, T.4.LN.BDC, 4+ 8- BDC+, Lymph Node, avg-3	KIF21B SP100 TOX BACH2 SIDT1 CHD7 PRAG1 MADD ARHGAP4 CCM2 CARD6 SSH2	1.48e-06	354	127	12	GSM605753_500
CoexpressionAtlas	CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3	KIF21B TOX BACH2 SIDT1 CHD7 MADD CCM2 TCP11L2 CARD6 SSH2 CDON	1.07e-05	359	127	11	GSM404000_500
CoexpressionAtlas	CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2	KIF21B SP100 TOX BACH2 SIDT1 CHD7 CARD6 CDON	6.18e-05	224	127	8	GSM403994_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5	ANK2 TOX NPAS3 FAXC CHD7 FOXN3 NSRP1 ADCYAP1R1 MADD AATK AKAP9 RTL1 LPIN2 CCDC106	6.52e-05	688	127	14	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5
CoexpressionAtlas	alpha beta T cells, T.4FP3-.Sp, 4+ 8- GFP- 44lo, Spleen, avg-3	KIF21B TOX BACH2 SIDT1 CHD7 PRAG1 MADD CARD6 SSH2 CDON	6.85e-05	364	127	10	GSM605766_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3	KIF21B SP100 WWP1 SIDT1 DGKH CHD7 PRAG1 MADD CARD6 PRRC2B	7.67e-05	369	127	10	GSM605891_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	SP100 HIRIP3 BACH2 NPAS3 CHD1 CHD7 FOXN3 WDR76 RTN2 NSRP1 MEIS1 JARID2 AATK AKAP9 RTL1 LPIN2 TACC1	8.20e-05	986	127	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	ANK2 HIRIP3 TOX NPAS3 FAXC CHD7 WDR76 RTN2 NSRP1 ADCYAP1R1 MADD AATK AKAP9 RTL1 LPIN2 TACC1	8.65e-05	893	127	16	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3	KIF21B SP100 TOX WWP1 SIDT1 CHD7 PRAG1 MADD CARD6 PRRC2B	1.04e-04	383	127	10	GSM538403_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3	KIF21B SP100 TOX WWP1 SIDT1 CHD7 PRAG1 MADD CARD6 PRRC2B	1.14e-04	387	127	10	GSM538392_500
CoexpressionAtlas	alpha beta T cells, T.8Nve.PP, TCR+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1	SP100 TOX BACH2 SIDT1 CHD7 PRAG1 CARD6 AKAP13 SSH2	1.25e-04	317	127	9	GSM538412_500
CoexpressionAtlas	alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2	SP100 TOX BACH2 SIDT1 CHD7 PRAG1 TCP11L2 CARD6 SSH2	1.58e-04	327	127	9	GSM538380_500
CoexpressionAtlas	alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2	SP100 TOX TAGAP BACH2 SIDT1 CHD7 SYNJ2 SSH2 CDON	1.61e-04	328	127	9	GSM605756_500
CoexpressionAtlas	alpha beta T cells, T.4.TI.B16, 4+ 8- TCR+ 45+, B16 Melanoma Tumor, avg-3	KIF21B TOX BACH2 SIDT1 PRAG1 CCM2 CARD6 SSH2 CDON	2.02e-04	338	127	9	GSM605763_500
CoexpressionAtlas	CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1	KIF21B SP100 TOX BACH2 SIDT1 CHD7 MADD CCM2 CARD6	2.02e-04	338	127	9	GSM403987_500
CoexpressionAtlas	alpha beta T cells, T.4Nve.MLN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3	KIF21B TOX TCOF1 BACH2 SIDT1 CHD7 PRAG1 CARD6 SSH2	2.30e-04	344	127	9	GSM538377_500
CoexpressionAtlas	CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4	KIF21B SP100 TOX BACH2 SIDT1 CHD7 CARD6	2.75e-04	210	127	7	GSM403995_500
CoexpressionAtlas	CD positive, CD4 Test CJ, 4+8-B220-, Spleen, avg-2	SP100 TOX TAGAP BACH2 SIDT1 CHD7 CARD6 SSH2	2.86e-04	280	127	8	GSM404003_500
CoexpressionAtlas	alpha beta T cells, T.8Nve.MLN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3	KIF21B TOX BACH2 SIDT1 CHD7 PRAG1 TCP11L2 CARD6 SSH2	2.96e-04	356	127	9	GSM538409_500
CoexpressionAtlas	CD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1	KIF21B TOX BACH2 SIDT1 CHD7 MADD TCP11L2 CARD6 CDON	3.02e-04	357	127	9	GSM403986_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2	KIF21B SP100 TOX WWP1 SIDT1 CHD7 PRAG1 CARD6 PRRC2B	3.27e-04	361	127	9	GSM538385_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#1	NAA38 KANK4 PAX3 BICC1	4.31e-04	59	127	4	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	HIRIP3 NPAS3 CHD1 CHD7 FOXN3 WDR76 NSRP1 AKAP9	4.34e-04	298	127	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+.Sp, TCRd+ Vg2+ CD44-, Spleen, avg-3	KIF21B TOX TAGAP BACH2 SIDT1 CCM2 TCP11L2 CARD6 SSH2	5.31e-04	386	127	9	GSM605787_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2	CENPT ANK2 TOX NPAS3 FAXC FOXN3 ADCYAP1R1 MADD PHKA2 AATK RTL1 LPIN2 CCDC106	5.44e-04	747	127	13	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2	ANK2 TOX BACH2 NPAS3 FAXC CHD7 ADCYAP1R1 MADD AATK RTL1 LPIN2 AKAP13 CCDC106	5.44e-04	747	127	13	Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3	KIF21B TOX TAGAP BACH2 SIDT1 PRAG1 TCP11L2 CARD6 SSH2	5.51e-04	388	127	9	GSM605790_500
CoexpressionAtlas	DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_1000	ANO4 KIF21B CACNB3 TCOF1 FNBP4 CHD7 GPATCH8 ZCCHC2 MEIS1 LPIN2 ANKRD11 PAX3 MAP4K4 INO80E	5.71e-04	850	127	14	gudmap_developingKidney_e11.5_metaneph mesench_1000
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	WDR70 PRAG1 JARID2 AKAP9 TCP11L2 SYNJ2 TACC1 MAP4K4	8.59e-08	193	127	8	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	SP100 WWP1 RNF13 NSRP1 AKAP9 LPIN2 ANKRD11 SECISBP2	1.09e-07	199	127	8	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SP100 BACH2 SIDT1 SNX29 CARD11 SSH2 MAP4K4	9.03e-07	181	127	7	8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TOX BACH2 JARID2 ARHGAP4 CARD11 SSH2 MAP4K4	1.05e-06	185	127	7	a2cae8c657e4f4d121476798e424876f7e247973
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TOX BACH2 JARID2 ARHGAP4 CARD11 SSH2 MAP4K4	1.05e-06	185	127	7	d50406a9a5b8d75110ba5985741aa2293950c543
ToppCell	Severe-B_activate-7\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TCOF1 TAGAP BACH2 ZCCHC2 TCP11L2 NFKB2 KDM4B	1.25e-06	190	127	7	67e6c8a5a8724bdf2861fd76a711319dfc71d47a
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	WDR70 PRAG1 JARID2 AKAP9 TCP11L2 SYNJ2 TACC1	1.34e-06	192	127	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SP100 TCOF1 TAGAP BACH2 CHD7 SNX29 KDM4B	1.39e-06	193	127	7	ac227ddabfb3f021b1b39dba73f898517cd5a58e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SP100 TCOF1 TAGAP BACH2 CHD7 SNX29 KDM4B	1.39e-06	193	127	7	f4135615ee0118eec9e221becdd67888e0c2a112
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SP100 TCOF1 TAGAP BACH2 CHD7 SNX29 KDM4B	1.44e-06	194	127	7	5cd72330c9d9bb21b6c9d5d35085eade101486d1
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	ANK2 BACH2 MEIS1 PHACTR3 FGFR4 PLEKHH2 BICC1	1.64e-06	198	127	7	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 BACH2 MEIS1 PHACTR3 FGFR4 PLEKHH2 BICC1	1.76e-06	200	127	7	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	SP100 TAGAP FNBP4 CHD1 FOXN3 NFKB2 ANKRD11	1.76e-06	200	127	7	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM121B CMYA5 PRAG1 PHACTR3 PAX3 CDON	5.56e-06	155	127	6	c58a5fb8d853f12204e961d633e83452eb12a659
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM121B CMYA5 PRAG1 PHACTR3 PAX3 CDON	5.56e-06	155	127	6	9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TOX PRAG1 FCHO1 PHACTR3 CARD6 CARD11	7.17e-06	162	127	6	0321fc954ae4ad67ca438cbbc84632562d222188
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TOX PRAG1 FCHO1 PHACTR3 CARD6 CARD11	7.17e-06	162	127	6	5731f9514434296132df4bc86f78ce87b07cdeca
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	XPC PNMA8B ARHGAP4 PHACTR3 FGFR4 PLEKHH2	8.82e-06	168	127	6	c66a61d3ec711796313a2c6d2dc39aedbfc20afd
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	XPC PNMA8B ARHGAP4 PHACTR3 FGFR4 PLEKHH2	8.82e-06	168	127	6	83b4f817d95daa15ae60668e789f97d8a3b2e6dd
ToppCell	droplet-Liver-HEPATOCYTES-1m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF21B TAGAP SIDT1 PRAG1 FCHO1 USP54	9.12e-06	169	127	6	d721dbb317a88113b4f76688111908d00f23e899
ToppCell	droplet-Fat-Bat-18m\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYBU WDR76 FAAP100 TCAIM KCNQ3 CCDC106	9.44e-06	170	127	6	c720d81bc29a8fd1f1249c6af408471d561f1d5d
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KIF21B TAGAP SIDT1 FCHO1 ARHGAP4 PPARGC1B	9.44e-06	170	127	6	bda900c836e0f2c1d7b442beb50b672d025b2420
ToppCell	droplet-Fat-Bat\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYBU WDR76 FAAP100 TCAIM KCNQ3 CCDC106	9.44e-06	170	127	6	c4ecdfc2b4710da0a5fbb20e9df02536023badb1
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF21B NOC2L SIDT1 NPAS3 LMBRD2 PPARGC1B	1.08e-05	174	127	6	6987fe7959afce347282f632abc16d800ccab7c4
ToppCell	COPD-Lymphoid-B\|COPD / Disease state, Lineage and Cell class	SP100 BACH2 SIDT1 CARD11 SSH2 MAP4K4	1.53e-05	185	127	6	925e79c35c381dd44ec5fb921dca09ce43140135
ToppCell	AT1_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CENPT ANK2 SCX AATK PHACTR3 KANK4	1.62e-05	187	127	6	f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 DGKH MEIS1 TCAIM KIF13A BICC1	1.67e-05	188	127	6	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 DGKH MEIS1 TCAIM KIF13A BICC1	1.67e-05	188	127	6	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 DGKH MEIS1 TCAIM KIF13A BICC1	1.67e-05	188	127	6	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	BAL-Control-Lymphocyte-B-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TOX TAGAP SYNJ2 NFKB2 CARD11 KDM4B	1.77e-05	190	127	6	da7341a8a423e5fe4d8e733d8e50c10a3318ac1c
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TOX TAGAP SYNJ2 NFKB2 CARD11 KDM4B	1.77e-05	190	127	6	42312f7d79fe889397d32910b625793e2535cc26
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TOX TAGAP SYNJ2 NFKB2 CARD11 KDM4B	1.77e-05	190	127	6	682418a7a2096743112eae3790d40e7e600612c0
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR70 SIDT1 ARHGAP4 MTOR CARD6	1.82e-05	113	127	5	357bc20edc5bc14eab8262d52260ed1686e9dc54
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-NK_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR70 SIDT1 ARHGAP4 MTOR CARD6	1.82e-05	113	127	5	91e73e3b93be242fef0f14eddd8085a1f1c730ef
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BACH2 MEIS1 SBNO2 SYNJ2 PLEKHH2 BICC1	1.83e-05	191	127	6	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	Fetal_29-31_weeks-Immune-B_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SP100 TAGAP BACH2 FCHO1 SNX29 CARD11	1.83e-05	191	127	6	84452125d1b5b76974e3f9126f611eff16d45c25
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK2 MEIS1 PHACTR3 FGFR4 PLEKHH2 BICC1	1.83e-05	191	127	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCOF1 TAGAP BACH2 CHD7 SNX29 NFKB2	1.88e-05	192	127	6	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCOF1 TAGAP BACH2 CHD7 SNX29 TCP11L2	1.88e-05	192	127	6	ef86d82e4f04f9f54e821ef496d70fc81072d773
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK2 MEIS1 PHACTR3 FGFR4 PLEKHH2 BICC1	1.88e-05	192	127	6	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP RNF13 CLASP2 LPIN2 TACC1 SSH2	1.94e-05	193	127	6	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCOF1 TAGAP CHD7 SNX29 TCP11L2 NFKB2	1.94e-05	193	127	6	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FOXN3 SNX29 JARID2 ANKRD11 AKAP13 SSH2	1.94e-05	193	127	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP RNF13 CLASP2 LPIN2 TACC1 SSH2	1.94e-05	193	127	6	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP RNF13 CLASP2 LPIN2 TACC1 SSH2	1.94e-05	193	127	6	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DGKH PRAG1 PHACTR3 SSH2 PLEKHH2 BICC1	1.94e-05	193	127	6	f42a0f02ed00fe1bb833ff0a0640d9131bca89bd
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	BACH2 MEIS1 PHACTR3 FGFR4 PLEKHH2 BICC1	1.94e-05	193	127	6	acad568621ed677031797b8c2e34dafea798d681
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DGKH PRAG1 PHACTR3 SSH2 PLEKHH2 BICC1	1.94e-05	193	127	6	42df7ed37d11fb542b4d1d714b6f87ae8e1396a6
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP RNF13 CLASP2 LPIN2 TACC1 SSH2	1.94e-05	193	127	6	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BACH2 MEIS1 PHACTR3 FGFR4 PLEKHH2 BICC1	1.99e-05	194	127	6	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	Control-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	HLX CHD1 JARID2 AATK ANKRD11 MAP4K4	1.99e-05	194	127	6	f852f5258617a66a4fbd56d64c7b47272e7b8b60
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DGKH PRAG1 PHACTR3 SSH2 PLEKHH2 BICC1	1.99e-05	194	127	6	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BACH2 DGKH PHACTR3 SSH2 PLEKHH2 BICC1	2.05e-05	195	127	6	938b31dbf1674ee6fd0123bc88391ddcaf151217
ToppCell	Healthy_donor-B_naive\|World / disease group, cell group and cell class (v2)	TCOF1 TAGAP BACH2 CHD7 SNX29 TCP11L2	2.05e-05	195	127	6	c66bbfdf0091cc62aa50edfa88820bbda191b7bb
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	BACH2 MEIS1 PHACTR3 FGFR4 PLEKHH2 BICC1	2.05e-05	195	127	6	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BACH2 DGKH PHACTR3 SSH2 PLEKHH2 BICC1	2.05e-05	195	127	6	d39e9e6544f49e677ebe528c6fe60b99a3630e30
ToppCell	Healthy/Control-B_naive\|Healthy/Control / Disease group and Cell class	TCOF1 TAGAP BACH2 CHD7 SNX29 TCP11L2	2.11e-05	196	127	6	e92d2c814d2dcb049f3e455fe66fd40898b3524d
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RRP15 CHD7 RTN2 PNMA8B FGFR4 MGARP	2.11e-05	196	127	6	3dc6394c5de1f875a19ad0e8799827fad29f8f02
ToppCell	Healthy_donor-B_naive\|Healthy_donor / disease group, cell group and cell class (v2)	TCOF1 TAGAP BACH2 CHD7 SNX29 TCP11L2	2.11e-05	196	127	6	cf254b1466357984201595fa32408d659eb741ef
ToppCell	Healthy/Control-B_naive\|World / Disease group and Cell class	TCOF1 TAGAP BACH2 CHD7 SNX29 TCP11L2	2.11e-05	196	127	6	ec935a4e16495c87b17070eb13c1e28bdb64e7ee
ToppCell	(5)_Fibroblast-J_(Lipofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ANK2 DACT2 MEIS1 ADCYAP1R1 BICC1 CDON	2.11e-05	196	127	6	afa29399decd17fda7d63add5039ff778627ccc2
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	SP100 CHD1 FOXN3 ZCCHC2 NFKB2 ANKRD11	2.17e-05	197	127	6	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	SP100 CHD1 FOXN3 ZCCHC2 JARID2 AKAP13	2.24e-05	198	127	6	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	SP100 CHD1 FOXN3 ZCCHC2 NFKB2 ANKRD11	2.24e-05	198	127	6	44417089b62056269cac38d3134ff209c05b7007
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	RNF13 CHD1 CCDC88A AKAP9 ANKRD11 SECISBP2	2.24e-05	198	127	6	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SP100 CHD1 FOXN3 ZCCHC2 NFKB2 ANKRD11	2.24e-05	198	127	6	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	WWP1 NSRP1 AKAP9 LPIN2 ANKRD11 SECISBP2	2.30e-05	199	127	6	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	CLASP1 WDR70 CLASP2 FOXN3 MEIS1 SSH2	2.30e-05	199	127	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	BACH2 DTL NPAS3 JARID2 KCNQ3 CDON	2.30e-05	199	127	6	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	SP100 CHD7 NSRP1 CCDC88A AKAP9 ANKRD11	2.30e-05	199	127	6	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related-Oligodendrocyte/OPC\|2m / Sample Type, Dataset, Time_group, and Cell type.	CHD7 PRAG1 MEIS1 ADCYAP1R1 KCNQ3 PAX3	2.37e-05	200	127	6	3c9a2f02294a9fb892b89e856291bd6423ffa0a9
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related\|2m / Sample Type, Dataset, Time_group, and Cell type.	CHD7 PRAG1 MEIS1 ADCYAP1R1 KCNQ3 PAX3	2.37e-05	200	127	6	8e49e7e9b02d8411e4ffae1f5113a2c18f5bf179
ToppCell	mLN-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	RNF13 SNX29 TCAIM AKAP9 ANKRD11 AKAP13	2.37e-05	200	127	6	e3c15e0e1c2602b0cc9ab8cc50c978d265350c94
ToppCell	Influenza-Influenza_Severe-Lymphocyte-B-B_naive\|Influenza_Severe / Disease, condition lineage and cell class	TCOF1 TAGAP BACH2 CHD7 SNX29 TCP11L2	2.37e-05	200	127	6	0e05600d725dc5cc9afccc11eedc60efa41e4e46
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	LARP6 ANK2 NPAS3 MEIS1 MGARP BICC1	2.37e-05	200	127	6	c082bc21ec7c5323439d108ea8aea510e1113c3f
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SP100 CHD1 ZCCHC2 AKAP9 ANKRD11 AKAP13	2.37e-05	200	127	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 BACH2 MEIS1 PHACTR3 PLEKHH2 BICC1	2.37e-05	200	127	6	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMFR RNF13 CLASP2 CCDC88A KIF13A MAP4K4	2.37e-05	200	127	6	f0c338877e39226a90c4effe12f6501d33542a73
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	KIF21B CALCOCO1 KIDINS220 AKAP9 PTPRO PHACTR3	2.37e-05	200	127	6	04699d1149a143b96d6f292c0d70c4d3e6dfc611
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	SP100 CHD1 ZCCHC2 ANKRD11 AKAP13 TACC1	2.37e-05	200	127	6	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BACH2 MEIS1 PHACTR3 FGFR4 PLEKHH2 BICC1	2.37e-05	200	127	6	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8\|TCGA-Thymus / Sample_Type by Project: Shred V9	KANK4 TACC1 PLEKHH2 MGARP BICC1	7.29e-05	151	127	5	5906562efd36fbcb91f96e0a0d3a8fe999ba1e79
ToppCell	facs-Marrow-KLS-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM121B PHACTR3 PAX3 BICC1 CDON	8.00e-05	154	127	5	37765512dfae557b9f6eb30a29463b93682a4404
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNB3 TAGAP JARID2 PTPRO CARD11	8.76e-05	157	127	5	d8e283414a770f05d71f0455d0822e9a9660b115
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNB3 TAGAP JARID2 PTPRO CARD11	8.76e-05	157	127	5	165e98bf944572cafbc06ef43c9eab7bd6bea1c2
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF21B PRAG1 LPIN2 CARD6 KIF13A	9.02e-05	158	127	5	1d78578dc1f8ba43dacdccae1082c0b9d749f64d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HIRIP3 BACH2 NPAS3 PTPRO MGARP	9.30e-05	159	127	5	fd7db2f7328cfefdc3ada2af91006d5a91d137e1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HIRIP3 BACH2 NPAS3 PTPRO MGARP	9.30e-05	159	127	5	aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HIRIP3 BACH2 NPAS3 PTPRO MGARP	9.30e-05	159	127	5	8bbdef1e927f3130b578d7d7c5ff38bbe06fab63
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TAGAP WWP1 RNF13 PTPRO CCDC106	9.86e-05	161	127	5	8937f6b92cb2a93ea8c4780d9200a518c3112e53
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	SYNM ZNF507 MTOR AKAP13 CARD11	1.02e-04	162	127	5	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	BL-critical-LOC-Myeloid-Basophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MIER2 KIF21B TMEM121B LMBRD2 RTN2	1.02e-04	162	127	5	25ec9df914445b4daae4fd28fd0e60b64797c46d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SP100 BACH2 SIDT1 ARHGAP4 CARD11	1.11e-04	165	127	5	7039bb5a7af4684fbd1192230864e5cd6936e83c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SP100 BACH2 SIDT1 ARHGAP4 CARD11	1.11e-04	165	127	5	d2c79653710b139794170f3d72f11392fc548ac7
ToppCell	facs-GAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP SIDT1 CHD7 FCHO1 CARD6	1.14e-04	166	127	5	3695407e4638f3c18fbff63daba52baa9256c429
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TAGAP BACH2 FCHO1 SNX29 CARD11	1.20e-04	168	127	5	eeb381b62c7ba263af96de1194ed59e57b6ca3ae
ToppCell	droplet-Fat-Bat-18m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAGAP MADD ARHGAP4 KCNQ3 CCDC106	1.20e-04	168	127	5	6fddc957a0503455d8c165862b5eb8e5fdb8a510
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TAGAP BACH2 FCHO1 SNX29 CARD11	1.20e-04	168	127	5	063d0368d656962b335154c230bdcd9236e7c9ad
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KIF21B TOX TAGAP SIDT1 CARD6	1.20e-04	168	127	5	6c758eb120faf06ff72d157b495e399191c79ec9
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF21B SP100 DTL SIDT1 WDR76	1.20e-04	168	127	5	ade02beb8d663fce4be2aefa10392ab849a4bbe7
Drug	5186223; Down 200; 12uM; MCF7; HT_HG-U133A_EA	CEP104 AMFR SP100 CENPT WDR76 NFKB2 LPIN2 RAB11FIP5 SNAPC2 GOLGA1	1.63e-07	197	127	10	885_DN
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	DTL WDR70 JARID2 AKAP9 LPIN2 ANKRD11 AKAP13 KDM4B	5.39e-06	171	127	8	7535_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	CLASP1 DTL WDR70 CLASP2 CHD7 MEIS1 JARID2 AKAP13	6.13e-06	174	127	8	7530_DN
Drug	0175029-0000 [211245-78-2]; Down 200; 1uM; MCF7; HT_HG-U133A	SYNM CYBC1 DTL ZCCHC2 MEIS1 SBNO2 TACC1 KDM4B	1.12e-05	189	127	8	4716_DN
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A	DCAF8 CALCOCO1 SIDT1 WDR76 MEIS1 TACC1 GOLGA1 KDM4B	1.36e-05	194	127	8	1670_DN
Drug	Clopamide [636-54-4]; Up 200; 11.6uM; PC3; HT_HG-U133A	CENPT DCAF8 TOX WDR76 RTN2 SBNO2 CCDC88A KIDINS220	1.41e-05	195	127	8	6301_UP
Drug	Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A	AMFR LARP6 CLASP1 FOXN3 CDC42BPB SYNJ2 MTOR PRRC2B	1.46e-05	196	127	8	5288_UP
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A	CACNB3 SP100 FCHO1 SBNO2 SYNJ2 SNAPC2 PRRC2A GOLGA1	1.57e-05	198	127	8	2392_DN
Drug	NSC150469	TAGAP CHM ANKRD11	7.34e-05	15	127	3	CID000052881
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	WWP1 DTL WDR70 CHD1 CHD7 JARID2 AKAP13	7.67e-05	183	127	7	7498_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A	SYNM CLASP2 FOXN3 ZCCHC2 SYNJ2 TACC1 KDM4B	8.21e-05	185	127	7	4755_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A_EA	NKX3-2 SYBU FOXN3 RTN2 PHKA2 CCDC88A AKAP13	8.78e-05	187	127	7	1047_UP
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	CENPT FOXN3 ZCCHC2 MEIS1 SBNO2 MTOR PRRC2A	1.04e-04	192	127	7	7176_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	SIDT1 WDR76 FCHO1 PHKA2 AKAP13 GOLGA1 PRRC2B	1.07e-04	193	127	7	3412_DN
Drug	Captopril [62571-86-2]; Up 200; 17.2uM; HL60; HG-U133A	CENPT FOXN3 RTN2 MADD SBNO2 ARHGAP4 KDM4B	1.07e-04	193	127	7	1988_UP
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	DCAF8 CALCOCO1 AKAP9 LPIN2 SECISBP2 FGFR4 PRRC2B	1.10e-04	194	127	7	1239_UP
Drug	Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A	HIRIP3 FAAP100 FCHO1 MEIS1 SBNO2 KIDINS220 PRRC2A	1.10e-04	194	127	7	7457_DN
Drug	Trichlorfon [52-68-6]; Down 200; 15.6uM; MCF7; HT_HG-U133A	AMFR SIDT1 CLASP2 WDR76 PHKA2 NFKB2 KDM4B	1.10e-04	194	127	7	1675_DN
Drug	Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A	CEP104 CLASP1 SYNM CLASP2 WDR76 SYNJ2 RAB11FIP5	1.10e-04	194	127	7	7354_DN
Drug	Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	SP100 CENPT DCAF8 MTOR SECISBP2 FGFR4 SNAPC2	1.14e-04	195	127	7	7225_DN
Drug	Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A	CENPT SYNM GPATCH8 SBNO2 SYNJ2 PRRC2A GOLGA1	1.14e-04	195	127	7	7022_UP
Drug	Edrophonium chloride [116-38-1]; Down 200; 19.8uM; HL60; HG-U133A	SP100 DCAF8 CCDC88A LPIN2 AKAP13 TACC1 PRRC2B	1.18e-04	196	127	7	2019_DN
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A	SP100 DCAF8 PHKA2 SYNJ2 RAB11FIP5 SECISBP2 PRRC2B	1.18e-04	196	127	7	1558_DN
Drug	Bergenin monohydrate [477-90-7]; Down 200; 11.6uM; MCF7; HT_HG-U133A	CALCOCO1 RRP15 SBNO2 KIDINS220 SYNJ2 MTOR FGFR4	1.18e-04	196	127	7	7224_DN
Drug	Carbimazole [22232-54-8]; Down 200; 21.4uM; HL60; HT_HG-U133A	CENPT NKX3-2 RTN2 KIDINS220 SYNJ2 SNAPC2 KDM4B	1.18e-04	196	127	7	2437_DN
Drug	2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A	SYBU MEIS1 ARHGAP4 LPIN2 RAB11FIP5 KDM4B CDON	1.18e-04	196	127	7	6934_UP
Drug	Mefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A	CCDC88A KIDINS220 SYNJ2 SECISBP2 AKAP13 CCDC106 KDM4B	1.18e-04	196	127	7	1821_UP
Drug	PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A	BACH2 CYBC1 CHD7 FOXN3 ZCCHC2 AATK KDM4B	1.18e-04	196	127	7	6591_DN
Drug	Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HG-U133A	HIRIP3 XPC MADD SBNO2 TACC1 NUP93 PRRC2B	1.18e-04	196	127	7	1961_UP
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	SP100 DCAF8 FCHO1 MADD SYNJ2 LPIN2 AKAP13	1.22e-04	197	127	7	5341_DN
Drug	Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A	CACNB3 SP100 CYBC1 MADD ANKRD11 AKAP13 FGFR4	1.22e-04	197	127	7	1795_DN
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	FOXN3 MADD SBNO2 PHKA2 SYNJ2 AKAP13 GOLGA1	1.22e-04	197	127	7	6930_DN
Drug	Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A	CENPT WDR76 MADD SBNO2 NFKB2 SNAPC2 PRRC2B	1.22e-04	197	127	7	4606_DN
Drug	Etofenamate [30544-47-9]; Down 200; 10.8uM; PC3; HT_HG-U133A	TOX CHD7 PHKA2 CCDC88A AATK SYNJ2 NFKB2	1.22e-04	197	127	7	3989_DN
Drug	Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A	CACNB3 SP100 DCAF8 SYNM KIDINS220 TACC1 KDM4B	1.22e-04	197	127	7	7472_DN
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; MCF7; HT_HG-U133A	SYBU WDR76 JARID2 PHKA2 NFKB2 TACC1 SNAPC2	1.25e-04	198	127	7	7497_UP
Drug	Deptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A	CEP104 CLASP2 SYBU AKAP9 NFKB2 RAB11FIP5 TACC1	1.25e-04	198	127	7	6523_DN
Drug	Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; HL60; HT_HG-U133A	CACNB3 TCOF1 ARHGAP4 SYNJ2 RAB11FIP5 AKAP13 PRRC2A	1.25e-04	198	127	7	1268_UP
Drug	Biotin [58-85-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A	SP100 LARP6 DCAF8 TCOF1 CALCOCO1 SYNJ2 TACC1	1.25e-04	198	127	7	3289_DN
Drug	Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A	CEP104 AMFR SYNJ2 MTOR RAB11FIP5 FGFR4 KDM4B	1.25e-04	198	127	7	2882_DN
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A	SBNO2 AKAP9 SYNJ2 AKAP13 TACC1 KIF13A KDM4B	1.29e-04	199	127	7	2319_DN
Drug	Thiamphenicol [15318-45-3]; Down 200; 11.2uM; PC3; HT_HG-U133A	AMFR CACNB3 SP100 HLX RTN2 AKAP9 SNAPC2	1.29e-04	199	127	7	7274_DN
Drug	Gabapentin [60142-96-3]; Down 200; 23.4uM; PC3; HT_HG-U133A	CACNB3 SP100 HLX FAAP100 SBNO2 LPIN2 CCDC106	1.29e-04	199	127	7	5875_DN
Drug	prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	HIRIP3 TOX RTN2 CCDC88A SYNJ2 BICC1 KDM4B	1.29e-04	199	127	7	6586_DN
Drug	Clebopride maleate [84370-95-6]; Down 200; 8.2uM; PC3; HT_HG-U133A	BACH2 CALCOCO1 HLX FOXN3 MEIS1 PHKA2 NFKB2	1.29e-04	199	127	7	6311_DN
Drug	Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A	DCAF8 CLASP2 MADD LPIN2 FGFR4 SNAPC2 PRRC2B	1.29e-04	199	127	7	7219_DN
Drug	Urosiol [128-13-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	CACNB3 NKX3-2 CLASP2 FCHO1 AKAP9 AKAP13 FGFR4	1.33e-04	200	127	7	6484_DN
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	DZIP1L MTOR BICC1	3.90e-05	16	124	3	DOID:0110861 (implicated_via_orthology)
Disease	Waardenburg Anophthalmia Syndrome	FNBP4 PAX3	5.24e-05	3	124	2	C0599973
Disease	neutrophil count	TAGAP BACH2 HLX DGKH CHD7 ZCCHC2 NAA38 FCHO1 SBNO2 AATK KIDINS220 ANKRD11 AKAP13 FGFR4 SSH2 MAP4K4 KDM4B	6.84e-05	1382	124	17	EFO_0004833
Disease	monocyte percentage of leukocytes	BACH2 CALCOCO1 HLX CHD7 FCHO1 SNX29 MADD MLLT1 AKAP13 SSH2 KDM4B	2.68e-04	731	124	11	EFO_0007989
Disease	wellbeing measurement, alcohol consumption measurement	TOX PARG CMYA5 NUP93	2.72e-04	74	124	4	EFO_0007869, EFO_0007878
Disease	eosinophil count	TMEM121B BACH2 HLX CHD1 DGKH CHD7 LMBRD2 ZNF785 SBNO2 SLC9A4 CCM2 AKAP9 ANKRD11 AKAP13 CARD11 MAP4K4	5.12e-04	1488	124	16	EFO_0004842
Disease	Congenital small ears	TCOF1 NKX3-2 CHD7	6.87e-04	41	124	3	C0152423
Disease	cerebral cavernous malformation (implicated_via_orthology)	CDC42BPB CCM2	9.40e-04	11	124	2	DOID:0060669 (implicated_via_orthology)
Disease	urate measurement, bone density	BACH2 PARG NPAS3 CLASP2 SNX29 MEIS1 KIDINS220 ANKRD11 PRRC2B	1.24e-03	619	124	9	EFO_0003923, EFO_0004531
Disease	Amino Acid Metabolism, Inherited Disorders	XPC SECISBP2	1.33e-03	13	124	2	C0750905
Disease	Amino Acid Metabolism, Inborn Errors	XPC SECISBP2	1.33e-03	13	124	2	C0002514
Disease	keratinocyte carcinoma	BACH2 SBNO2 PPARGC1B ANKRD11	1.58e-03	118	124	4	EFO_0010176
Disease	nervousness	FNBP4 MADD	2.02e-03	16	124	2	NCIT_C74532
Disease	Romano-Ward Syndrome	ANK2 AKAP9	2.02e-03	16	124	2	C0035828
Disease	verbal-numerical reasoning measurement	FOXN3 SNX29 PHACTR3 RAB11FIP5	2.31e-03	131	124	4	EFO_0008394
Disease	neutrophil percentage of granulocytes	BACH2 CHD1 CHD7 AKAP13 CARD11	2.82e-03	228	124	5	EFO_0007994
Disease	squamous cell carcinoma	BACH2 PPARGC1B ANKRD11	2.85e-03	67	124	3	EFO_0000707
Disease	insulin sensitivity measurement, body mass index	TOX NPAS3	2.86e-03	19	124	2	EFO_0004340, EFO_0004471
Disease	eosinophil percentage of granulocytes	BACH2 CHD1 CHD7 AKAP13 CARD11	3.15e-03	234	124	5	EFO_0007996
Disease	asthma, age at onset	BACH2 SBNO2 MAP4K4	3.23e-03	70	124	3	EFO_0004847, MONDO_0004979
Disease	ST2 protein measurement	SLC9A4 MAP4K4	3.49e-03	21	124	2	EFO_0010599
Disease	Granulomatous Slack Skin	NFKB2 CARD11	3.83e-03	22	124	2	C0376407
Disease	mean platelet volume	NRDC PCNX3 SIDT1 CHD7 NAA38 CDC42BPB MEIS1 SCARF1 CTR9 ANKRD11 PACSIN2	3.88e-03	1020	124	11	EFO_0004584
Disease	Lymphoma, T-Cell, Cutaneous	NFKB2 CARD11	4.18e-03	23	124	2	C0079773
Disease	chronic widespread pain	WDR70 CDON	4.18e-03	23	124	2	EFO_0010099

Protein segments in the cluster

Peptide	Gene	Start	Entry
LSFSSDSEGNFETPE	TACC1	51	O75410
DESGSFSEADSESCP	BACH2	591	Q9BYV9
EGRGEESESATDSFP	AKAP9	2926	Q99996
SDPESTDDGSLSEET	AKT1S1	146	Q96B36
STESSEEEDAPSFAP	ANKRD11	296	Q6UB99
SEVSSDSFTDRGQEP	ANKRD11	1301	Q6UB99
EDSEAGSADSYTSRP	CACNB3	11	P54284
ITGDSLTSSNDDEDP	FGFR4	116	P22455
ESGSDSDLFHSPSDD	AKAP13	1436	Q12802
TGSSDDRSAPSEGDE	CCM2	406	Q9BSQ5
SPDDQFLVSGSSDEA	DTL	326	Q9NZJ0
ENRSEPESDGSEFSG	ANO4	836	Q32M45
AAQSDPGSNSERSTD	BICC1	11	Q9H694
DAAGRDSPSNTSQSE	CHD7	776	Q9P2D1
SPSQSGSDSESEEER	CHD1	156	O14646
SGEDALDFTQESEPS	NUP93	151	Q8N1F7
TEAADSAFLPTEDES	CHM	131	P24386
PSVFGNDSDDDDETS	NSRP1	26	Q9H0G5
VSSRFSEEGPRSTDD	RAB11FIP5	371	Q9BXF6
PNAEEESGSSSASEE	INTS3	1006	Q68E01
DASSDSTGADPAQEA	LACRT	21	Q9GZZ8
LDNSVASPSTGDDDD	MEIS1	251	O00470
YSDRGDDSPDSSPEE	ANK2	3266	Q01484
STPPFSSEEDSEGDR	DZIP1L	611	Q8IYY4
TAEPSRFSSSDSDFD	FCHO1	336	O14526
EDEGAENSFSRTPDT	FAXC	371	Q5TGI0
ADESTSGPEDTRAAS	MAP4K4	786	O95819
RNAGSSSDGTEDSDF	KAT7	6	O95251
EDAAEGLSSPTDSSR	KIDINS220	1181	Q9ULH0
FNSESESGSEASSPD	HIRIP3	96	Q9BW71
RDSDSEPTDDSGSDS	MADD	611	Q8WXG6
SGDDFASDGSSSRED	GOLGA1	41	Q92805
SPSRSEGEAESESSD	HLX	366	Q14774
ERSPSGFSISQDRDD	KCNQ3	801	O43525
SFEDISPQGVSDDSS	CCDC88A	1561	Q3V6T2
SQPSSGDEDSDDASS	GPATCH8	811	Q9UKJ3
DEDTSEGSELSPASS	PCNX3	421	Q9H6A9
DAGNSRSEDSPADST	MUC19	176	Q7Z5P9
ETSPGFDEQEDGSSS	PARG	321	Q86W56
VGATDADSDESPSSS	DCAF8	566	Q5TAQ9
DSGSEESLVDSDSDP	KIF21B	611	O75037
ASSDEEASPFSGEED	KDM4B	631	O94953
GDESSANSSSDPESN	LARP6	331	Q9BRS8
VSSPSDTSNFDVDDD	CDC42BPB	361	Q9Y5S2
SAGPGEDSSDSEAEQ	DGKH	31	Q86XP1
SRSTSQDDRDSEDGD	FAAP100	96	Q0VG06
NFSDSDSSEEEEGPF	NOC2L	96	Q9Y3T9
PFLDDSSGSEEEDSS	PLEKHH2	616	Q8IVE3
GESDFGDSNSLDLSD	ADCYAP1R1	96	P41586
DATASSDNSETEGTP	INO80E	71	Q8NBZ0
DSASAAPESEDEFVS	PTPRO	301	Q16827
FFTDQSSRDPLEDGD	PTF1A	26	Q7RTS3
ASAPQSDEGSDIDSE	PAX3	196	P23760
PSPDSDSDSDSDGEE	PPP1R37	501	O75864
SASVSGDRSPRTEDD	NKX3-2	151	P78367
SNPFDDDATSGTEVR	PACSIN2	416	Q9UNF0
IGDPADFSDESNTAS	CEP104	151	O60308
DFENSETTEFSGEEP	CARD6	246	Q9BX69
TNRFGDRESSSSDEE	DACT2	691	Q5SW24
DRESSSSDEEGGAQS	DACT2	696	Q5SW24
DPESAASSLSGASEE	CCDC106	131	Q9BWC9
EGSFRSHESPSDTEE	FOXN3	381	O00409
SEGEDLGSERFTPDS	CMYA5	781	Q8N3K9
ARDDEGVPNSDSSTD	CENPJ	691	Q9HC77
SGDEDASGRAASPES	CENPT	386	Q96BT3
DVSSDGSEDPAEFSR	CDON	1196	Q4KMG0
PSAESDHESERGSDN	CTR9	1126	Q6PD62
ELSQSSDSEAGDPAS	CYBC1	171	Q9BQA9
ENSPAESESSAGDDL	MGARP	211	Q8TDB4
QSSSSAGDSDGERED	NAA38	21	Q9BRA0
SGEDSTPEDLSDSEA	KANK4	681	Q5T7N3
PGRDSRLSFSDSESD	MLLT1	431	Q03111
LSGPAEDSSSDSEAE	CALCOCO1	586	Q9P1Z2
GQEADDSSTSEESPE	CARD11	471	Q9BXL7
ASEGTFSPDSDSDLV	PHKA2	631	P46019
EDREPGSSASSDTEE	MIER2	171	Q8N344
TSNDVSSSDFEEGPS	JARID2	91	Q92833
GSNSESEAESTENSP	MTOR	1846	P42345
VSSSRPDLSGFDEDD	KIF13A	1391	Q9H1H9
DSSATSSADAGENPD	PHACTR3	26	Q96KR7
ADDETSDQPSSDGSD	RTL1	571	A6NKG5
SDQPSSDGSDDLSES	RTL1	576	A6NKG5
TPDSTEGGNDDSDFR	RTN2	21	O75298
ETDQSSSDGQEPFST	TCAIM	91	Q8N3R3
PGAGESSEDNSDRSS	SNX29	286	Q8TEQ0
GEDQPSDSDSSRFSE	TCP11L2	11	Q8N4U5
GSPSSSTGAEREDDD	TMEM121B	66	Q9BXQ6
DSNDPDVESNSSSGI	TAGAP	311	Q8N103
VSESPQEDSAEDTSG	SYNM	1376	O15061
DSPQLSGATDSQDDS	SYNJ2	561	O15056
SGATDSQDDSSPADI	SYNJ2	566	O15056
SEESDSDGEAPAAVT	TCOF1	936	Q13428
VTAAAASDDSPSEDE	FNBP4	61	Q8N3X1
PSSEDEDTAEATSGI	AATK	856	Q6ZMQ8
NAETFTDDPLESESG	LMBRD2	661	Q68DH5
PVDSDTSESDSQESG	PNMA8B	306	Q9ULN7
RERSDSGGSSSEPFD	PRRC2A	756	P48634
SSSSGESSFLPEEEE	PPARGC1B	796	Q86YN6
VPSQGDSDSDTDSSQ	RNF13	286	O43567
RDTRAAGFSDDDSSD	SLC9A4	671	Q6AI14
AVSPAFTSDDTQDGE	SECISBP2	551	Q96T21
ISDDSSTESDPGLDS	SBNO2	651	Q9Y2G9
STESDPGLDSDFNSS	SBNO2	656	Q9Y2G9
ERTPSFSASDGDSDG	SAMD11	46	Q96NU1
DGHSSSNPDSRDSDD	NPAS3	516	Q8IXF0
DSFSSDPESGEADEV	SCARF1	521	Q14162
SDDGDVLDSFQTSPS	ARHGAP4	396	P98171
SDDSGEETDESFNPG	SSRP1	471	Q08945
PEDSSEDTSGTENEA	BRPF1	1036	P55201
SSEDDAASESFLPSE	AMFR	601	Q9UKV5
FDDEDSVDGNRPSSA	CLASP1	241	Q7Z460
DEESVDGNRPSSAAS	CLASP2	11	O75122
DSNSEDSGNPSTTRF	ZCCHC2	661	Q9C0B9
EGFTEQSSTTDEPSA	SSH2	1141	Q76I76
ESPFSEEESREFNPS	SYBU	46	Q9NX95
EEESREFNPSSSGRS	SYBU	51	Q9NX95
SEQSSDSSDDELIGP	WDR70	106	Q9NW82
PGQSDTDSSVEESDF	SIDT1	391	Q9NXL6
FSESSEEEAPAEASS	SP100	406	P23497
EEDGTPSSEDSNSSC	NRDC	1096	O43847
SNSSEEEAREAGSPA	PRRC2B	601	Q5JSZ5
SDGPDDSRPESASDS	RRP15	266	Q9Y3B9
DDSDQRCSPSGDSEG	PRAG1	236	Q86YV5
SEESADPVTGSSENA	ZNF507	846	Q8TCN5
SQDGDSDEDTTPSLD	WDR76	141	Q9H967
ELSSGEASDPSDEDS	XPC	446	Q01831
EPADDTVNGESSSFA	WWP1	236	Q9H0M0
PLSEDEDRGSDSSGS	SCX	21	Q7RTU7
SPSSSVHEDEGDDTS	TOX	216	O94900
ESSAGPSTEEDFAVD	SNAPC2	191	Q13487
EAQDPDGESSAAFSR	ZNF785	91	A8K8V0
YDSEDSGREPSISSD	USP54	376	Q70EL1
GARPAENDSSSDEGS	LPIN2	596	Q92539
SDSDSDSEGPEKDTR	NFKB2	711	Q00653